Biotechnology AIM ImmunoTech Promising Ovarian Cancer Trial ResultsBy MohamedMis2July 21, 2023 AIM ImmunoTech Inc. (AIM) has achieved a significant breakthrough in ovarian cancer treatment. As evidenced by the positive data from…
Drug Manufacture MorphoSys Awaits Pivotal Phase 3 Clinical DataBy MohamedMis2July 11, 2023 In a highly anticipated move, JP Morgan analyst Michael Nuen suggests that MorphoSys, the German biotech company, could experience a…
Drug Manufacture InnoCare Revolutionizes Blood Cancer TreatmentBy MohamedMis2July 7, 2023 InnoCare, a leading biopharmaceutical company, has received approval in Hong Kong for the use of its tafasitamab combination therapy in…
